An update: Cancer-associated anorexia as a treatment target

Research output: Contribution to journalReview articlepeer-review

15 Scopus citations


Loss of appetite is pervasive among patients with advanced cancer. Cancer patients cite it as one of their most troubling symptoms. To date, however, palliative options remain limited. Megestrol acetate and dexamethasone provide only modest relief. Novel agents such as thalidomide, adenosine triphosphate, and other cytokine inhibitors merit further investigation.

Original languageEnglish (US)
Pages (from-to)179-182
Number of pages4
JournalCurrent opinion in clinical nutrition and metabolic care
Issue number3
StatePublished - May 1 2001

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics


Dive into the research topics of 'An update: Cancer-associated anorexia as a treatment target'. Together they form a unique fingerprint.

Cite this